-
Mashup Score: 1Diabetes Dialogue: STEP-HFpEF Reaction - 2 year(s) ago
Less than 2 weeks after the release of their SELECT reaction podcast, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down for a special edition episode of Diabetes Dialogue to discuss STEP-HFpEF data and the implications for semaglutide 2.4 mg.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD - 2 year(s) ago
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of individualizing nutrition in diabetes management, and the sessions she led and moderated at ADCES 2023.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Catch up on the latest #ADCES23 episode of #DiabetesDialogue this weekend! Check out the preview below: https://t.co/zx1amk7nWy https://t.co/IEMPKS5Enf
-
-
Mashup Score: 0Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD - 2 year(s) ago
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of individualizing nutrition in diabetes management, and the sessions she led and moderated at ADCES 2023.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
We launched the latest #DiabetesDialogue earlier today! Hear from @dawnnoe2 as she joins @DianaMIsaacs and @natalie_bellini to discuss #nutrition in diabetes and #ADCES23: https://t.co/Wv6lOkGYhu https://t.co/JwwpWqJJSk
-
-
Mashup Score: 0Diabetes Dialogue: ADCES 2023 Recap - 2 year(s) ago
In this episode, which is the first of multiple special edition ADCES 2023 episodes, hosts hold an overarching discussion of the meeting itself and major themes from the ADCES’s 50th anniversary celebration.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
In this #DiabetesDialogue—the first of multiple special edition #ADCES2023 episodes—@DianaMIsaacs and @natalie_bellini hold a discussion of the meeting itself and major themes from the ADCES's 50th anniversary celebration: https://t.co/B5AiuBvhRh #Diabetes https://t.co/bT3AHZ07aR
-
-
Mashup Score: 0
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexagliflozin to the Cost Plus Drugs platform and topline data from the landmark SELECT trial.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Earlier this week, we launched the latest episode of #DiabetesDialogue. Hear from @DianaMIsaacs and @natalie_bellini on the latest developments in #diabetes management: https://t.co/dDzSF1i0ug https://t.co/Lf9uml89Q4
-
-
Mashup Score: 0
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexagliflozin to the Cost Plus Drugs platform and topline data from the landmark SELECT trial.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
In the latest #DiabetesDialogue, @DianaMIsaacs and @natalie_bellini sit down for a discussion on the implications of bexagliflozin's addition to @costplusdrugs and SELECT results: https://t.co/uIXccnJqWW #Diabetes #Obesity https://t.co/4ete3VB32w
-
-
Mashup Score: 0
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and provides an overview of the efforts of the Time in Range Coalition to advance use and education around time in range.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Need a breakdown on the optimal role of time in range in the management of #diabetes? Check out this #DiabetesDialogue episode with @DianaMIsaacs and @natalie_bellini with Julie Heverly of @diaTribeNews from #ADA2023: https://t.co/q6W0ubKKDE https://t.co/i9mV7ek1XM
-
-
Mashup Score: 0
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and provides an overview of the efforts of the Time in Range Coalition to advance use and education around time in range.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Need a breakdown on the optimal role of time in range in the management of #diabetes? Check out this #DiabetesDialogue episode with @DianaMIsaacs and @natalie_bellini with Julie Heverly of @diaTribeNews from #ADA2023: https://t.co/q6W0ubKKDE https://t.co/ngufFJiX6e
-
-
Mashup Score: 0Diabetes Dialogue: ADA 2023 Recap - 2 year(s) ago
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss their top takeaways from ADA 2023.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Last week, @DianaMIsaacs and @natalie_bellini hosts of #DiabetesDialogue, sat down to record a recap of their top takeaways from #ADA2023. In this clip, Isaacs discusses data from orforglipron: https://t.co/sjQqijIk3S #Diabetes https://t.co/2cbfLCwAIk
-
-
Mashup Score: 0Diabetes Dialogue: ADA 2023 Recap - 2 year(s) ago
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss their top takeaways from ADA 2023.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Need a refresher on #ADA2023? #DiabetesDialogue hosts @DianaMIsaacs and @natalie_bellini have you covered in our recap episode. https://t.co/zGc6k4i8h3 https://t.co/AkcOwcQbWn
-
Less than 2 weeks after releasing their SELECT reaction podcast, @DianaMIsaacs and @natalie_bellini sit down for a special edition episode of #DiabetesDialogue to discuss STEP-HFpEF data and the implications for semaglutide 2.4 mg. https://t.co/eVvChsGnRy #ESCCongress2023 https://t.co/Hzns8fRabk